ArticleOncotarget2016

Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.

Julia M A Pickl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.